Marker Therapeutics Announces Board Resignation

Houston-based biopharmaceutical company Marker Therapeutics, Inc., with a market capitalization of $20.45 million, reported a change in its board composition earlier this week. On Thursday, the firm announced the resignation of Mr. John Wilson from its Board of Directors, effective January 24, 2025. The details surrounding Mr. Wilson's departure have not been disclosed, and the company has not named a successor at this time.

You May Also Be Interested In

• NVIDIA, Mitsubishi Heavy Industries eye cooperation on AI data center cooling and power - Nikkei
• Warsh: we plan on getting rid of tax that is inflation
• Barclays: 'IBM’s comments around client prioritization of security bodes well for the space overall'